濮阳东方医院割包皮手术专业濮阳东方妇科医院技术很靠谱,濮阳东方医院男科治早泄技术比较专业,濮阳东方看男科收费低吗,濮阳东方医院治疗早泄很好,濮阳市东方医院看病好又便宜,濮阳东方医院男科割包皮手术比较专业,濮阳东方妇科医院做人流价格不贵

CAPE CANAVERAL, Florida, April 29, (Xinhua) -- NASA on Friday delayed space shuttle Endeavor's launch to no earlier than Monday afternoon due to technical problems with heaters in the shuttle's auxiliary power unit."Shuttle Endeavor's launch now no earlier than Monday at 2:33 p. m. EDT (1833 GMT)," NASA said. "Engineers need that time to troubleshoot an issue that resulted in today's launch scrub."During Friday's countdown, engineers detected a failure in one of two heater circuits associated with Auxiliary Power Unit (APU) 1. Heaters are required to keep the APUs' hydrazine from freezing on orbit.Space shuttle Endeavour sits on the launch pad at the Kennedy Space Center at Cape Canaveral, Florida,  April 28, 2011. The Endeavor is scheduled for a Friday afternoon launch.U.S. President Barack Obama, touring storm damage in Alabama on Friday, had been expected to attend the planned 3:47 p.m. (1947 GMT) launch. Obama will still visit Cape Canaveral and then travel to Miami, where he is scheduled to speak at a community college commencement.Endeavor's 14-day mission will deliver the Alpha Magnetic Spectrometer-2 (AMS) to the International Space Station. AMS, a particle physics detector, is designed to search for various types of unusual matter by measuring cosmic rays.Its experiments are designed to help researchers study the formation of the universe and search for evidence of dark matter, strange matter and antimatter. Endeavor also will fly the a platform that carries spare parts that will sustain space station operations once the shuttles are retired from service.The mission will feature four spacewalks to do maintenance work and install new components. These are the last scheduled spacewalks by shuttle crew members.Endeavor, which has been promised to the California Science Center in Los Angeles upon its return, was the replacement ship for Challenger, which was lost in a 1986 explosion as it ascended over the Atlantic that killed seven astronauts.It will be the second of NASA's three surviving shuttles to be retired. Sister ship Discovery, which will be transferred to the Smithsonian National Air and Space Museum, completed its last flight in March.Atlantis' final launch is scheduled for June 28. When the U.S. space shuttle program officially ends later this year, the Russian space program's Soyuz capsule will be the only method for transporting astronauts to and from the station.

LOS ANGELES, May 2 (Xinhua) -- An asteroid will fly past Earth this fall at a close approach that will allow a close-up view of one of Earth's good-sized space rocks, NASA's Jet Propulsion Laboratory (JPL) announced on Monday."On November 8, asteroid 2005 YU55 will fly past Earth and at its closest approach point will be about 325,000 kilometers away," said Don Yeomans, manager of NASA's Near-Earth Object Program Office at the JPL in Pasadena, Los Angeles."This asteroid is about 400 meters wide -- the largest space rock we have identified that will come this close until 2028."Despite the relative proximity and size, "YU55 poses no threat of an Earth collision over, at the very least, the next 100 years, " Yeomans said in a press release."During its closest approach, its gravitational effect on the Earth will be so miniscule as to be immeasurable. It will not affect the tides or anything else.""While near-Earth objects of this size have flown within a lunar distance in the past, we did not have the foreknowledge and technology to take advantage of the opportunity," said Barbara Wilson, a scientist at JPL. "When it flies past, it should be a great opportunity for science instruments on the ground to get a good look.""The best resolution of the radar images was 7.5 meters per pixel," said JPL radar astronomer Lance Benner. "When 2005 YU55 returns this fall, we intend to image it at 4-meter resolution with our recently upgraded equipment at the Deep Space Network at Goldstone, California. Plus, the asteroid will be seven times closer. We're expecting some very detailed radar images."Asteroid 2005 YU55 was discovered in December 2005 by Robert McMillan, head of the NASA-funded Spacewatch Program at the University of Arizona, Tucson. The space rock has been in astronomers' crosshairs before.In April 2010, Mike Nolan and colleagues at the Arecibo Observatory in Puerto Rico generated some ghostly images of 2005 YU55 when the asteroid was about 2.3 million kilometers from Earth.

WASHINGTON, May 17 (Xinhua) -- A variation in a gene involved in regulating cholesterol in the bloodstream also appears to affect progesterone production in women, making it a likely culprit in a substantial number of cases of their infertility, a new study from Johns Hopkins University researchers suggests.The Hopkins group has also developed a simple blood test for this variation of the scavenger receptor class B type 1 gene ( SCARB1) but emphasized there is no approved therapy yet to address the problem in infertile women.Following up studies in female mice that first linked a deficiency in these receptors for HDL -- the so-called "good" or " healthy" cholesterol -- and infertility, researchers report finding the same link in studies of women with a history of infertility.The findings has been published on-line this week in the journal Human Reproduction.If the new study's findings hold up on further investigation, the John Hopkins team says they not only will offer clues into a genetic cause of some infertility, but could also lead to a treatment already shown to work in mice."Infertility is fairly common and a lot of the reasons for it are still unknown," warns endocrinologist Annabelle Rodriguez, an associate professor of medicine at the Johns Hopkins University School of Medicine and the lead author. "Right now, the benefit of this research is in knowing that there might be a genetic reason for why some women have difficulty getting pregnant. In the future, we hope this knowledge can be translated into a cure for this type of infertility."

LIMA, May 5 (Xinhua) -- A total of 53.5 million people in Latin America and the Caribbean suffer from hunger or malnutrition, experts said at an international forum here Thursday.Juan Garcia, coordinator of the 5th work-group meeting of the Latin American and Caribbean Initiative Without Hunger, said the figure has not increased since 1990.Experts and officials from 13 countries gathered to discuss the challenges facing regional food security and advances that have been made, hoping to make cooperative efforts to eradicate hunger and malnutrition by the year 2025.Carcia said people affected most across the continent are still those living in rural areas as well as African descendants and indigenous people who suffer from "exclusion and inequality."The main cause of undernutrition is not lack of food-production capacity, but access to food, Carcia said.Six countries, Brazil, Ecuador, Venezuela, Guatemala, Honduras and Nicaragua, have approved food security laws with nine more in the process of doing so. The laws are considered as a way to ensure that local agricultural products are primarily used to feed the countries' own populations and not used for export.

WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.